Vol. 43 No. 1 (2026)

Click for printable cover

Published: 27-03-2026

  • Interstitial lung disease in psoriasis: A systematic review and meta-analysis

    Jonas A. Baekdal, Laura Bjerken, Erik Sören Halvard Hansen, Laurits K. Janns, Howraman Meteran, Charlotte Suppli Ulrik, Elisabeth Bendstrup
    17851
    DOI: https://doi.org/10.36141/svdld.2026.17851

  • Combination antifibrotic and immunosuppressive therapy in progressive fibrosing ILD

    Ryan Fischer, Khawaja Abdul Rehman
    18462
    DOI: https://doi.org/10.36141/svdld.2026.18462

  • Methylprednisolone in the management of post-COVID-19 interstitial lung disease: A randomized trial (STERCOV-ILD)

    Aycan Yüksel, Dilek Karadoğan, Nur Hürsoy, Tahsin Gökhan Telatar, Neslihan Köse Kabil, Feride Marım, İlknur Kaya, Aslıhan Banu Er, Merve Erçelik, Demet Polat Yuluğ, Merve Yumrukuz Şenel, Ceren İlgar, Ökkeş Gültekin, Selin Çakmakcı Karakaya, Bilge Yılmaz Kara, Neslihan Özçelik, İnci Selimoğlu, Kübra Uyar Er, Abdurrahman Kotan, Hasan Veysel Keskin, Metin Akgün
    17022
    DOI: https://doi.org/10.36141/svdld.2026.17022

  • Assessment of sarcopenia in female patients with sarcoidosis upon initial diagnosis

    Cesur Samancı, Vefa Salt, Bilal Demir, Rauf Hamid, Ömer Faruk Sarıahmetoğlu, Kerime Hatun Acar, Seyfullah Halit Karagöz, Ahmet Üstündağ, Buket Çalışkaner Öztürk, Ersan Atahan, Fatma Ateş Ustabaşoğlu, Ahmet Baş
    17176
    DOI: https://doi.org/10.36141/svdld.2026.17176

  • Combined impact of ROR2 and its ligands on the pathogenesis and prognosis of idiopathic pulmonary fibrosis

    Seung-Lee Park, Jong-Uk Lee, Min Kyung Kim, Eunjeong Seo, Myung-Shin Kim, Hun Gyu Hwang, Jung Hyun Kim, Hun Soo Chang, Choon-Sik Park
    17921
    DOI: https://doi.org/10.36141/svdld.2026.17921

  • Intrapulmonary unicentric Castleman’s Disease: A clinical analysis of 8 patients

    Linling Jin, Yiting He, Chenyang Liu, Songtao Liu, Shuying Ma, Nan Li, Hui Kong, Weiping Xie, Mengyu He
    18073
    DOI: https://doi.org/10.36141/svdld.2026.18073

  • Prognostic significance of incorporating SpO2 recovery time to the 6-minute walk test protocol and to a modified GAP index risk prediction model in patients with idiopathic pulmonary fibrosis

    Elif Yildirim, Nisanur Tutus, Yagmur Aydogdu, Ipek Ozmen
    18270
    DOI: https://doi.org/10.36141/svdld.2026.18270

  • Prevalence of thyroid autoantibodies in a large series of sarcoidosis patients: Implications for autoimmune thyroid disease screening

    Elias Giallafos, Evangelos Oikonomou, Ourania Katsarou, Lykourgos Kolilekas, Evangelos Markozanes, Kostas Zisimos, Gesthimani Seitaridi, Maria Gazouli, Efrosyni Manali, Spyros Papiris, Gerasimos Siasios, Ioannis Ilias
    18306
    DOI: https://doi.org/10.36141/svdld.2026.18306

  • Late-Onset Sjögren disease: A different clinical entity?

    Celil Barlas Cengiz, Tuğba Kahraman Denizhan, Hüseyin Kaplan, Emel Oğuz Kökoğlu, Melih Kızıltepe, Burcu Eren Cengiz, Hanife Oğuz, Abdurrahman Soner Şenel
    18390
    DOI: https://doi.org/10.36141/svdld.2026.18390

  • Impact of pulmonary hypertension on mortality in progressive massive fibrosis

    Serhat Özgün, Gülden Sarı, Adem Koyuncu, Rabia Ezber, Mücahid Alp Arslan, Fatih Mehmet Doğan, Şahbender Koç, Ceprail Şimşek
    18391
    DOI: https://doi.org/10.36141/svdld.2026.18391

  • .

    Lofgren's syndrome: A clinical puzzle in a case of monoarthritis

    Emre Ali Acar, Sadettin Uslu
    18095
    DOI: https://doi.org/10.36141/svdld.2026.18095
  • .

    Histopathologic overlap between fibrotic sarcoidosis and UIP pattern

    Wai Ling Leong, Venerino Poletti, Claudia Ravaglia, Sara Piciucchi
    18332
    DOI: https://doi.org/10.36141/svdld.2026.18332

  • Subclinical cardiac involvement: A subtle foe in the setting of systemic sarcoidosis

    Kenan Yalta, Ugur Ozkan, Irem B Bulburu, Muhammet Gurdogan, Ertan Yetkın
    18297
    DOI: https://doi.org/10.36141/svdld.2026.18297